Physical fatigue and perceived fatigability in adolescents and adults with spinal muscular atrophy: A pilot study by Domine, M.C., Cattinari, M.G., de Lemus, M., Castellano, I.P., Ñungo-Garzón, N.C., Sevilla-Mantecón, T., Vázquez-Costa, J.F.

Get full text

Validación de Neuromyotype: un teclado inteligente para la evaluación de pacientes con atrofia muscular espinal 5q by Lizandra Cortés, P., Poveda Verdú, D., Albert Férriz, A., Ñungo-Garzón, N.C., Domine, M.C., Sevilla-Mantecón, T., Pitarch-Castellano, I., Vázquez-Costa, J.F.

Get full text

High {0 0 1} faceted TiO2 nanoparticles for the valorization of oxygenated compounds present in aqueous biomass-derived feedstocks by Fernández-Arroyo, A., Lara, M.A., Domine, M.E., Sayagués, M.J., Navío, J.A., Hidalgo, M.C.

Get full text

Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinic... by Esteban, E, Majem, M, Martinez Aguillo, M, Martinez Banaclocha, N, Dómine, M, Gómez Aldaravi, L, Juan, O, Cajal, R, Gonzalez Arenas, M.C, Provencio, M

Get full text

PD2.02 Pembrolizumab plus Pemetrexed-Platinum for Patients with Metastatic Nonsquamous NSCLC and Liver or Brain Metastases: Results from KEYNOTE-189 by Garassino, M.C., Gadgeel, S., Esteban, E., Felip, E., Speranza, G., De Angelis, F., Domine, M., Clingan, P., Hochmair, M.J., Powell, S.F., Cheng, S.Y.-S., Bischoff, H.G., Peled, N., Grossi, F., Jennens, R.R., Reck, M., Hui, R., Garon, E.B., Boyer, M., Rubio-Viqueira, B., Novello, S., Kurata, T., Gray, J.E., Cardellino, A., Yang, J., Pietanza, M.C., Rodríguez-Abreu, D.

Get full text

LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation by Jänne, P.A., Smit, E.F., de Marinis, F., Laskin, J., Gomez, M. Domine, Gadgeel, S., Garassino, M.C., Lu, S., Spira, A.S., Kang, V., Roshan, S., Yan, X., Felip, E.

Get full text

PD.1.01 Health-Related Quality of Life with Pembrolizumab or Placebo + Pemetrexed + Platinum in Non-Squamous NSCLC: KEYNOTE-189 by Garassino, M., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., Speranza, G., Domine, M., Hochmair, M., Powell, S., Cheng, S., Bischoff, H., Peled, N., Reck, M., Hui, R., Garon, E., Boyer, M., Yang, J., Burke, T., Pietanza, M.C., Gandhi, L.

Get full text

FP13.02 Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189 by Gray, J., Rodríguez-Abreu, D., Powell, S.F., Hochmair, M.J., Gadgeel, S., Esteban, E., Felip, E., Speranza, G., De Angelis, F., Dómine, M., Cheng, S.Y., Bischoff, H.G., Peled, N., Reck, M., Hui, R., Garon, E.B., Boyer, M., Kurata, T., Yang, J., Jensen, E., Souza, F., Garassino, M.C.

Get full text